Genome editing technologies have been invented and improved in recent years, and there is a growing expectation that the technologies can be utilized as a tool not only for molecular biological studies, but also for genetic therapies. Among them, CRISPR‐Cas9 system that was originally found as a part of the bacterial adaptive immune system gets noticed for its easy introduction. Here, users are only required to design a guide RNA with a 20‐nt sequence that is complementary to the target DNA sequence and co‐express Cas9 with the RNA in vivo, then Cas9 protein will cleave the target DNA in a site‐specific manner. This is a portrait of a kabuki actor who plays Cas9 as indicated by the crest “ku” (‘nine’) on kimono he is wearing. The “actor” definitely has a promising future ahead of him. Designed by TRAIS Co., Ltd. (Kobe, Japan)

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2443|20|4|i-i

ISSN: 1356-9597

Source: GENES TO CELLS, Vol.20, Iss.4, 2015-04, pp. : i-i

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract